JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 3 No. 6, June 1994 TABLE OF CONTENTS
  Archives
 • Online Features
  Clinical Reviews
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Selected Factors That Influence Responses to Antihypertensives

Choosing Therapy for the Uncomplicated Patient

Barry L. Carter, PharmD; Edward D. Frohlich, MD; William J. Elliott, MD, PhD; Michael A. Moore, MD; R. Jerry Mann, MD; Raymond W. Roberts, PharmD

Arch Fam Med. 1994;3(6):528-535.


Abstract



Numerous factors may influence an individual patient's response to antihypertensive therapy. The physician should select therapy that is more likely to effectively control the patient's blood pressure. In addition to age and race, specific properties of the drugs plus the method of administration can influence response. Most antihypertensives can be given once or twice daily without the need for sustained-release dosage forms. The appropriate selection of regular-release products can significantly reduce the cost of therapy and improve adherence to the regimen. Because most antihypertensives exist as isomers of two compounds, response to a given agent can be influenced by the type of product (eg, sustainedrelease) or the method of administration. When these variables are considered for individual patients, it is more likely that a given drug will be effective.



Author Affiliations



From the Department of Pharmacy Practice, University of Illinois at Chicago (Dr Carter); the Department of Preventive Medicine, Rush-Presbyterian-St Luke's Medical Center, Chicago (Dr Elliot); the Alton Ochsner Medical Foundation, New Orleans, La (Dr Frohlich); the Department of Medicine, Bowman Gray School of Medicine, Winston-Salem, NC (Dr Moore); the Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill (Dr Moore); the Department of Nephrology, Danville (Va) Urologic Clinic (Dr Moore); the Department of Family and Community Medicine, University of Arkansas for Medical Sciences, Little Rock (Dr Mann); and Home Infusion Services, Foxmeyer Corporation, Carrollton, Tex (Dr Roberts).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hydrochlorothiazide Versus Chlorthalidone: Evidence Supporting Their Interchangeability
Carter et al.
Hypertension 2004;43:4-9.
ABSTRACT | FULL TEXT  




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.

DCSIMG